Mintz On Air

In this episode of the EXCLUSIVE RIGHTS: Intellectual Property podcast, Mintz Intellectual Property attorneys Andrew Skale and Daniel Weinger explore copyright protections for music and other creative works. This episode was triggered by Dan’s interest in music copyrights generally and by recent high-profile cases filed by Marvin Gaye’s estate. Dan asks Andrew what musicians, artists, and authors...

In this episode of the EXCLUSIVE RIGHTS: Intellectual Property podcast, patent attorney Lily Zhang talks with trademark attorney Karen Won about the age-old choice between adopting descriptive brands or distinctive brands for businesses and products. As Karen tells us, trademark law is more art than science. Why is it that “bagel thins” can eventually become a trademark, but "pretzel crisps” can n...

In this episode of the Health Law Diagnosed podcast, Mintz’s Susan Berson discusses her career trajectory, the benefits of building a diverse and inclusive workplace, why women may be drawn to health law, and the importance of mentorship and sponsorship.

Please join your favorite SPAC corporate attorneys, Tom Burton, Sahir Surmeli, and Jeff Schultz as they set the record straight on SPACs’ apparent boom and bust, heavily reported on in the media. In this episode, they will address the few reasons why SPAC transactions have slowed down, including the SEC’s heightened scrutiny, the question over company valuations, and recent market shifts. They wil...

This past year has been a busy one for the FDA, but it hasn’t all been about the pandemic. FDA attorneys Joanne Hawana and Benjamin Zegarelli discuss the agency's ongoing efforts to protect the public from unproven COVID-19 cures while also pushing forward with its most important regulatory priorities, such as digital health, cannabis-derived compounds, and laboratory-developed tests and other dia...

It seems that everyone is taking a second look at SPACs as the number of lawsuits against these alternative IPOs continues to increase by the day. The SEC has recently commented on the liability risks of SPACs under the securities laws following the agency’s heightened scrutiny of these blank-check companies. What exactly is happening, and how can SPAC actors mitigate the ever-increasing risk of l...

The ability to provide health care from a remote location has been around for many years, but with the arrival of COVID-19, hospitals, physicians, and other health care providers have had to rapidly rethink their traditional models of health care delivery. This episode explores the many changes to the telehealth regulatory landscape necessitated by the pandemic, including expansions in Medicare an...

There is no denying the surge in special purpose acquisition companies (SPACs) and that these financing vehicles have had a significant impact on financial markets. Join your favorite SPAC attorneys as they discuss the key trends highlighted in Mintz’s comprehensive new SPAC report produced in collaboration with PitchBook, Breaking Down the SPAC Surge: A Review of Key Trends & Issues Defining...

At the end of 2020, the US Department of Health and Human Services Office of Inspector General and Centers for Medicare and Medicaid Services issued final rules modifying and expanding upon the regulatory safe harbors and exceptions to the federal Anti-Kickback Statute and the Stark Law, respectively. In Part 2 of this two-part series, Mintz’s Karen Lovitch and Rachel Yount return to examine the c...

Does a minimal investment in a Special Purpose Acquisition Company (SPAC) entitle a sponsor to a tremendous amount of equity after a successful IPO? Hypothetically speaking, will an investment of $25,000 for founder shares result in approximately $40 million of equity value upon completion of a $200 million SPAC IPO? What is at risk for SPAC sponsors and what are the controversies surrounding spon...

At the end of 2020, the U.S. Department of Health and Human Services Office of Inspector General and Centers for Medicare and Medicaid Services issued final rules modifying and expanding upon the regulatory safe harbors and exceptions to the federal Anti-Kickback Statute and the Stark Law, respectively. In Part 1 of this two-part series, Mintz’s Karen Lovitch and Rachel Yount examine the changes t...

Special Purpose Acquisition Companies (SPACs) are taking over Wall Street as more and more companies are taking advantage of this alternative IPO strategy. However, SPACs didn’t always have the best reputation, with many analysts warning against their growing popularity. Grab a cup of coffee and listen as leading SPAC attorneys from Mintz discuss and debunk the four most common myths about these t...

In this podcast, Sebastian Lucier speaks with Carl Dumesle, one of the winners of the USD School of Business Fowler Business Concept Challenge, about the experiences of launching a company as a student and engaging with academic institution resources available to student entrepreneurs.

Mounting anxiety over how to control the spread of infectious disease outbreaks encourages public and political discourse of bioethics. In the third episode of Mintz’s Health Law Diagnosed, Mintz’s Bridgette Keller talks about the legal, public health, and bioethics concerns inherent in a global pandemic, including allocating scarce medical resources such as COVID-19 vaccine, and how the greatest...

Despite dramatic improvements in the overall health of the population, racial and ethnic disparities in health and in our health care delivery system persist. In the second episode of Mintz’s Health Law Diagnosed, Dr. Tom Sequist of Mass General Brigham speaks to Mintz’s Brent Henry about what health care providers can do to help break down the barriers that perpetuate our country’s health care in...

In the inaugural episode of Mintz’s Health Law Diagnosed, Dianne Bourque (Member, Mintz Health Law Practice) discusses why HIPAA is so engrained in our collective consciousness, how it was already equipped to handle public health emergencies, and the important changes made over the last several months to address the COVID-19 outbreak.  

In this podcast, Lonnie Adelman, founder and president of iAssay, Inc., a point of care medical diagnostic company, explains how he started and built his company, the benefits to medical professionals of his cloud-connected technology, the applications that help in our fight against the COVID-19 pandemic, and the challenges he faced in fundraising.

In this podcast, Eric Shnell, the founder of Craitor, developer of a ruggedized 3D printer for military use, discusses how he founded and funded his company while a student at UC San Diego and how the innovative UC San Diego Accelerator Program known as “The Basement” helped Craitor build its team, develop and build its prototype, and raise initial grant monies.

In this podcast, Jeremy Glaser, Co-chair of the Mintz Venture Capital & Emerging Companies practice, and Ryan Floyd, founder and partner at Storm Ventures, discuss important points for entrepreneurs to be aware of when negotiating a venture capital term sheet.

In the second installment of Mintz’s multi-part series addressing common questions relating to establishing a new enterprise, Sam Effron and Sebastian Lucier discuss the issuance of shares to the founders, the mechanics and reasoning behind vesting and some important tax consequences relating to share issuances.

In this podcast, Jake Shapiro, the founder of RadioPublic and Podfund, explores the current state of the podcasting market and industry trends.

In this episode of MintzEdge’s From the Edge podcast, David Ponraj, a physicist-turned-analyst-turned-entrepreneur, tells Aditya Perakath, a physicist-turned-Mintz attorney, how he started his current venture: a startup designed to help other startups succeed.

In this episode of MintzEdge’s From the Edge podcast, Sam Effron speaks with Ben Zegarelli of Mintz about considerations for new medical device, pharmaceutical, or other health regulated start-ups and strategies for how to prepare for FDA oversight.

In this podcast, Una Ryan, a successful life sciences entrepreneur and investor, shares her fascinating story of how she came to the United States and became a successful life sciences entrepreneur, investor, and artist – and offers important tips to help entrepreneurs achieve successs.

In this podcast, Jeremy Glaser discusses with John M. Morris the value of mentors and the role they can play in both early stage and later stage companies.